The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIRELS, H. (1989) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198912000-00027 · Cited by 1,214
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
Self-citationEfficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352401 · Cited by 1,026
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Hortobagyi, G. N., Theriault, R. L., Lipton, A., Porter, L., Blayney, D., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J. J., Knight, R. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2038 · Cited by 631
Theriault, R. L., Lipton, A., Hortobagyi, G. N., Leff, R., Glück, S., Stewart, J. F., Costello, S., Kennedy, I., Simeone, J., Seaman, J. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.846 · Cited by 604
Paterson, A. H., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J., & Ashley, S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.59 · Cited by 557
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma
Lahtinen, R., Laakso, M., Palva, I., Elomaa, I., & Virkkunen, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)93075-x · Cited by 385
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
Hillner, B. E., Ingle, J. N., Berenson, J. R., Janjan, N. A., Albain, K. S., Lipton, A., Yee, G., Biermann, J. S., Chlebowski, R. T., Pfister, D. G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1378 · Cited by 383
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body, J. J., Bartl, R., Burckhardt, P., Delmas, P. D., Diel, I. J., Fleisch, H., Kanis, J. A., Kyle, R. A., Mundy, G. R., Paterson, A. H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.12.3890 · Cited by 359
Jagdev, S. P., Coleman, R. E., Shipman, C. M., Rostami-H, A., & Croucher, P. I. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1727 · Cited by 346
Self-citationSaarto, T., Blomqvist, C., Virkkunen, P., & Elomaa, I. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.10 · Cited by 341
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma
McCloskey, MacLennan, Drayson, Chapman, Dunn, Kanis, & Adults, F. T. M. W. P. O. L. I. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00567.x · Cited by 314
C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system
Bataille, R., Boccadoro, M., Klein, B., Durie, B., & Pileri, A. (1992) · Blood · doi:10.1182/blood.v80.3.733.733 · Cited by 294
Clinical course and prognostic factors following bone recurrence from breast cancer
Coleman, R., Smith, P., & Rubens, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.52 · Cited by 293
Self-citationRogers, M. J., Watts, D. J., & Russell, R. G. G. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1652::aid-cncr15>3.0.co;2-z · Cited by 285
Lewington, V. J., McEwan, A. J., Ackery, D. M., Bayly, R. J., Keeling, D. H., Macleod, P. M., Porter, A. T., & Zivanovic, M. A. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90257-e · Cited by 279
Conte, P. F., Latreille, J., Mauriac, L., Calabresi, F., Santos, R., Campos, D., Bonneterre, J., Francini, G., & Ford, J. M. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2552 · Cited by 268
Saarto, T., Blomqvist, C., Välimäki, M., Mäkelä, P., Sarna, S., & Elomaa, I. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1341 · Cited by 265
Resche, I., Chatal, J.-F., Pecking, A., Ell, P., Duchesne, G., Rubens, R., Fogelman, I., Houston, S., Fauser, A., Fischer, M., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00155-x · Cited by 254
van Holten-Verzantvoort, A. T., Bijvoet, O. L. M., Hermans, J., Harinck, H. I. J., Elte, J. W. F., Beex, L. V. A. M., Cleton, F. J., Kroon, H. M., Vermey, P., Neijt, J. P., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92555-4 · Cited by 202
Vinholes, J., Purohit, O. P., Abbey, M. E., Eastell, R., & Coleman, R. E. (1997) · Annals of Oncology · doi:10.1023/a:1008238422151 · Cited by 163
Self-citationHigh-dose intravenous pamidronate for metastatic bone pain
Purohit, O., Anthony, C., Radstone, C., Owen, J., & Coleman, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.344 · Cited by 158
Self-citationA Dose-Finding Study of Zoledronate in Hypercalcemic Cancer Patients
Body, J. J., Lortholary, A. H., Romieu, G., Vigneron, A.-M., & Ford, J. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1557 · Cited by 151
Generalised Increase in Bone Resorption in Carcinoma of the Prostate
Urwin, G. H., PERCIVAL, R. C., HARRIS, S., Beneton, M. N. C., Williams, J. L., & Kanis, J. А. (1985) · British Journal of Urology · doi:10.1111/j.1464-410x.1985.tb07040.x · Cited by 140
Markers of bone resorption in patients treated with pamidronate
Lipton, A., Demers, L., Curley, E., Chinchilli, V. M., Gaydos, L. J., Hortobágyi, G. N., Theriault, R. L., Clemens, D., Costa, L., Seaman, J. J., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00277-9 · Cited by 139
Ernst, D. S., Brasher, P. M. A., Hagen, N. A., Paterson, A. H. G., MacDonald, R. N., & Bruera, E. D. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00075-4 · Cited by 101
Coleman, R. E., Purohit, O. P., Black, C., Vinholes, J., Schlosser, K., Huss, H., Quinn, K. J., & Kanis, J. A. (1999) · Annals of Oncology · doi:10.1023/a:1008386501738 · Cited by 95
Self-citationEisenberger, M., Crawford, E. D., Wolf, M. C., Blumenstein, B. A., McLeod, D. G., Benson, R., Dorr, F. A., Benson, M., & Spaulding, J. T. (1994) · PubMed · Cited by 90
Use of bisphosphonates in cancer patients
Body, J., Coleman, R. E., & Piccart, M. J. (1996) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(96)90020-1 · Cited by 89
Self-citationHOW IS ANDROGEN-DEPENDENT METASTATIC PROSTATE CANCER BEST TREATED?
Robson, M., & Dawson, N. A. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70364-6 · Cited by 71
Rogers, M. J., Xiong, X., Ji, X., Mönkkönen, J., Russell, R. G. G., Williamson, M. P., Ebetino, F. H., & Watts, D. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012157212793 · Cited by 68
van der Pluijm, G., Löwik, C. W. G. M., & Papapoulos, S. E. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0143 · Cited by 56
Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.
Yoneda, T., Michigami, T., Yi, B., Williams, P. J., Niewolna, M., & Hiraga, T. (1999) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0133 · Cited by 52
Hultborn, R., Gundersen, S., Rydén, S., et al. (1996) · Acta Oncologica · doi:10.3109/02841869609083974 · Cited by 33
Cited by
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Body, J.-J., Facon, T., Coleman, R. E., Lipton, A., Geurs, F., Fan, M., Holloway, D., Peterson, M. C., & Bekker, P. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1933 · Cited by 490
Self-citationCancer pain and its impact on diagnosis, survival and quality of life
Mantyh, P. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1914 · Cited by 441
Scagliotti, G. V., Hirsh, V., Siena, S., Henry, D. H., Woll, P. J., Manegold, C., Solal-Celigny, P., Rodriguez, G., Krzakowski, M., Mehta, N. D., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826aec2b · Cited by 335
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens
Conte, P., & Guarneri, V. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-28 · Cited by 241
Metadata
- Authors
- Coleman, R. E.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 27
- Issue
- 3
- Pages
- 165-176
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2161962336
- Cited by
- 1,920
- References
- 36
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
